FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck

Histopathology

Volumn 63, Issue 2, 2013, Pages 263-270

  Pattje, W J ^a   Melchers, L J ^a   Slagter Menkema, L ^a   Mastik, M F ^a   Schrijvers, M L ^a   Gibcus, J H ^a   Kluin, P M ^a   Hoegen Chouvalova, O ^a   van der Laan, B F A M ^a   Roodenburg, J L N ^a   van der Wal, J E ^b   Schuuring, E ^a   Langendijk, J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

Distant metastasis; FADD; Head and neck neoplasms; Lymphatic metastasis

Indexed keywords

FAS ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER TISSUE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; DISTANT METASTASIS FREE INTERVAL; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGIONAL METASTASIS; TUMOR BIOPSY;

EID: 84880723268     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12174     Document Type: Article

References (31)

1. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat. Rev. Cancer 2005; 5; 127-135.
2. Vermorken JB, Specenier P. Optimal treatment for recurrent/metastatic head and neck cancer. Ann. Oncol. 2010; 21(Suppl. 7); vii252-vii261.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010; 127; 2893-2917.
4. Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J. Dent. Res. 2007; 86; 104-114.
5. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat. Rev. Cancer 2011; 11; 9-22.
6. Licitra L, Felip E. ESMO Guidelines Working Group. Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 2009; 20(Suppl. 4); 121-122.
7. Vermorken JB. Medical treatment in head and neck cancer. Ann. Oncol. 2005; 16(Suppl. 2); ii258-ii264.
8. Chen Y, Chen C. DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review. Head Neck 2008; 30; 1361-1383.
9. Gibcus JH, Menkema L, Mastik MF et al. Amplicon mapping and expression profiling identify the fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin. Cancer Res. 2007; 13; 6257-6266.
10. Haddad RI, Shin DM. Recent advances in head and neck cancer. N. Engl. J. Med. 2008; 359; 1143-1154.
11. Gibcus JH, Kok K, Menkema L et al. High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications. Hum. Genet. 2007; 121; 187-201.
12. Liu HS, Lu HH, Lui MT et al. Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers. Oral Oncol. 2009; 45; 1032-1036.
13. Brown LA, Johnson K, Leung S et al. Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers. Breast Cancer Res. Treat. 2010; 121; 347-354.
14. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996; 12; 1-9.
15. Tourneur L, Chiocchia G. FADD: a regulator of life and death. Trends Immunol. 2010; 31; 260-269.
16. Lavrik IN, Krammer PH. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ. 2012; 19; 36-41.
17. Green DR, Oberst A, Dillon CP, Weinlich R, Salvesen GS. RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol. Cell 2011; 44; 9-16.
18. Gordy C, He YW. The crosstalk between autophagy and apoptosis: where does this lead? Protein Cell 2012; 3; 17-27.
19. Werner MH, Wu C, Walsh CM. Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation. Cell Cycle 2006; 5; 2332-2338.
20. Pattje WJ, Schuuring E, Mastik MF et al. The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer. Br. J. Cancer 2010; 102; 1778-1785.
21. Schrijvers ML, Pattje WJ, Slagter-Menkema L et al. FADD expression as a prognosticator in early-stage glottic squamous cell carcinoma of the larynx treated primarily with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2012; 83; 1220-1226.
22. Gibcus JH, Mastik MF, Menkema L et al. Cortactin expression predicts poor survival in laryngeal carcinoma. Br. J. Cancer 2008; 98; 950-955.
23. Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes-a review. Gene 1995; 159; 83-96.
24. Rasamny JJ, Allak A, Krook KA et al. Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma. Otolaryngol. Head Neck Surg. 2012; 146; 923-931.
25. Prapinjumrune C, Morita K, Kuribayashi Y et al. DNA amplification and expression of FADD in oral squamous cell carcinoma. J. Oral Pathol. Med. 2010; 39; 525-532.
26. Peter ME. Programmed cell death: apoptosis meets necrosis. Nature 2011; 471; 310-312.
27. Welz PS, Wullaert A, Vlantis K et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 2011; 477; 330-334.
28. Feoktistova M, Geserick P, Panayotova-Dimitrova D, Leverkus M. Pick your poison: the ripoptosome, a cell death platform regulating apoptosis and necroptosis. Cell Cycle 2012; 11; 460-467.
29. Galluzzi L, Kepp O, Kroemer G. FADD: an endogenous inhibitor of RIP3-driven regulated necrosis. Cell Res. 2011; 21; 1383-1385.
30. Matsuyoshi S, Shimada K, Nakamura M, Ishida E, Konishi N. FADD phosphorylation is critical for cell cycle regulation in breast cancer cells. Br. J. Cancer 2006; 94; 532-539.
31. Foger N, Bulfone-Paus S, Chan AC, Lee KH. Subcellular compartmentalization of FADD as a new level of regulation in death receptor signaling. FEBS J. 2009; 276; 4256-4265.